New Delhi: JB Chemicals & Pharmaceuticals today reported a 7.23 per cent rise in its standalone net profit to Rs. 45.19 crore for the quarter ended September 30, mainly on account of robust domestic formulations sales.
The company had posted a net profit of Rs. 42.14 crore during the same period a year ago, JB Chemicals & Pharmaceuticals said in a filing to BSE.
The company's total income from operations also rose to Rs. 301.48 crore during the quarter under review as against Rs. 291.01 crore in the year-ago period.
In another filing, the company said its board of directors has appointed Manoj R Mashru as additional director of the company. He is an independent director on the board.
He will hold the office of additional director to the date of next Annual General Meeting (AGM), it added.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
The company had posted a net profit of Rs. 42.14 crore during the same period a year ago, JB Chemicals & Pharmaceuticals said in a filing to BSE.
The company's total income from operations also rose to Rs. 301.48 crore during the quarter under review as against Rs. 291.01 crore in the year-ago period.
In another filing, the company said its board of directors has appointed Manoj R Mashru as additional director of the company. He is an independent director on the board.
He will hold the office of additional director to the date of next Annual General Meeting (AGM), it added.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
Story first published on: November 18, 2016 17:31 (IST)
No comments:
Post a Comment